Bayesian Health Announces LifeBridge Health Partnership and Creation of Advisory Board with Founding Members Lee Sacks, MD and Gary E. Bisbee, Jr., PhD

LifeBridge Health Selects Bayesian Health’s Artificial Intelligence Platform to Help Diagnose and Treat Pressure Ulcers, Sepsis, and Patient Worsening

Posted: October 20, 2021 at 10:00 a.m. EDT|Update: 4 hours ago

NEW YORK, 20 October 2021 / PRNewswire / – Bayesian Health today announced that LifeBridge Health will deploy its AI-based clinical decision support platform to help diagnose and treat pressure ulcers, sepsis and patient deterioration. Bayesian Health’s platform operates within Epic and Cerner’s electronic medical records (EMR), deploying cutting-edge artificial intelligence and machine learning (AI / ML) strategies to detect patient complications at an early stage.

Bayesian Health’s research-based AI platform takes existing EMR data, analyzing patient, clinical and third-party data with its cutting-edge AI / ML models. The platform sends accurate and actionable clinical signals into existing workflows when a critical condition is detected, helping physicians and healthcare team members to accurately diagnose, intervene and deliver timely care . The technology also includes a performance optimization engine that helps secure long-term engagement of physicians, nurses and healthcare teams with the tool.

“Like all healthcare systems, our physicians have to sift through vast amounts of healthcare data when making decisions about patient care. As we look for ways to support our teams, we are interested to see how this new tool can work in the current workflow while still allowing for some customization to increase the decision making process for each vendor or firm. “, Explain Tressa Springmann, Senior Vice President and Chief Information Officer at LifeBridge Health.

“LifeBridge has always sought new and innovative ways to deliver high quality, compassionate care, and Bayesian Health’s research-backed platform will help physicians and members of the LifeBridge Health care team to fulfill this mission ”, declared Suchi Saria, CEO of Bayesian Health. “I am also delighted to welcome Lee and Gary to Bayesian Health as founding members of our Advisory Board. They recognize the immense opportunity for health systems to improve patient outcomes and save lives by leveraging the Bayesian Platform to increase decision making for physicians and nurses. with crucial data. “

Lee Bags, MD, is the former Chief Medical Officer at Advocate Aurora, responsible for Safety, Quality, Population Health, Insurance, Claims, Risk Management, Research and Medical Education . Previously, he was Executive Vice President, Medical Director of Advocate Health Care as well as Founding CEO of Advocate Physician Partners.

“Health systems remain under market pressure to improve outcomes while reducing costs,” said Lee Bags, MD. “Although healthcare systems have made substantial investments in their EMRs over the past decades, most struggle to leverage their data in a way that helps clinicians improve outcomes. in the marketplace and as a platform solution applied to many clinical areas, I believe it will enable healthcare systems to achieve the dual purpose of improving outcomes while reducing costs. “

Gary E. Bisbee, Jr., PhD, is Founder, President and CEO of Think Medium, a digital media company focused on healthcare leadership, and serves on the Board of Directors of Cerner. Prior to Think Medium, Bisbee was Co-Founder, President and CEO of The Health Management Academy, and he served as CEO and held various board positions at ReGen Biologics, Inc., Aros Corporation and APACHE Medical Systems, Inc.

According to Gary E. Bisbee, Jr, PhD, “Creating technology that can analyze and appropriately manage EMR and healthcare data is difficult. Building technology that doctors and nurses want to use every day is even more difficult. The Bayesian platform is ideally positioned. to bridge the gap between the baseline data and the information a clinician needs to support a care decision. Accurate, actionable clinical decision support – which physicians want to use – is long overdue in space, and the impact Bayesian Health will have on patient outcomes will be substantial. “

With a research-driven foundation of over 21 patents and peer-reviewed research papers, Bayesian Health approaches the market with a transparent and results-driven strategy. He recently published a large study on five sites analyze the impact of use and practice over two years for Bayesian’s sepsis module. The platform enabled faster antibiotic treatment of 1.85 hours and demonstrated high and sustained adoption by physicians and nurses (89% adoption), driven by the sensitivity and accuracy of information and l user experience of the software.

Bayesian Health’s technology overcomes common barriers faced by many field workers by using cutting-edge strategies to increase accuracy, Make the stronger models, and encourage behavior change and continued use. As a result, Bayesian’s technology is 10 times more accurate than other solutions on the market, delivering tangible results for patients. To learn more about Bayesian Health, visit

Bayesian Health’s mission is to make healthcare proactive by giving physicians and healthcare team members real-time data to save lives. Just as top physicians continually incorporate new data to refine their prognosis for what is happening with a patient, Bayesian Health’s research-based AI platform integrates every piece of data available to provide physicians and nurses precise and actionable clinical signals that allow them to diagnose, intervene and provide proactive and better care.

Show original content:

SOURCE Bayesian Health

The above press release has been provided courtesy of PRNewswire. The views, opinions and statements contained in the press release are not endorsed by Gray Media Group and do not necessarily state or reflect those of Gray Media Group, Inc.

Source link

Steven L. Nielsen

Leave a Reply

Your email address will not be published. Required fields are marked *